Smith Salley Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-60,096
| Closed | -$3.05M | – | 184 |
|
|
2017
Q3 | $3.05M | Sell |
60,096
-366
| -0.6% | -$18.6K | 0.58% | 66 |
|
|
2017
Q2 | $3.26M | Buy |
60,462
+1,404
| +2% | +$75.7K | 0.66% | 61 |
|
|
2017
Q1 | $3.11M | Buy |
59,058
+2,087
| +4% | +$110K | 0.64% | 58 |
|
|
2016
Q4 | $2.74M | Sell |
56,971
-1,152
| -2% | -$55.4K | 0.57% | 61 |
|
|
2016
Q3 | $3.13M | Buy |
58,123
+9,313
| +19% | +$502K | 0.69% | 57 |
|
|
2016
Q2 | $2.65M | Buy |
48,810
+8,310
| +21% | +$450K | 0.62% | 60 |
|
|
2016
Q1 | $2.05M | Buy |
40,500
+438
| +1% | +$22.2K | 0.51% | 62 |
|
|
2015
Q4 | $2.02M | Buy |
40,062
+12,567
| +46% | +$634K | 0.5% | 65 |
|
|
2015
Q3 | $1.32M | Buy |
27,495
+1,039
| +4% | +$50K | 0.36% | 81 |
|
|
2015
Q2 | $1.38M | Buy |
26,456
+1,218
| +5% | +$63.4K | 0.35% | 83 |
|
|
2015
Q1 | $1.46M | Buy |
25,238
+5,316
| +27% | +$307K | 0.37% | 80 |
|
|
2014
Q4 | $1.06M | Buy |
19,922
+8,047
| +68% | +$430K | 0.28% | 94 |
|
|
2014
Q3 | $682K | Buy |
+11,875
| New | +$682K | 0.18% | 116 |
|